InsidersTradesSigma
Follow the PHARMANUTRA PR PHARMANUTRA - PHN - THE BOARD OF DIRECTOR APPROVES THE 2022 SUSTAINABILITY REPORT stock price and the full insider trade history of the company, a listed equity based in Italy. Shares trade on the IT market, under the supervision of Consob. Operating in the Health Care sector, PHARMANUTRA PR PHARMANUTRA - PHN - THE BOARD OF DIRECTOR APPROVES THE 2022 SUSTAINABILITY REPORT has logged 0 reports. Market capitalisation: €784.2m. All data is accessible without an account.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,492 of 29,064 companies
61.9
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.6%
EV/EBITDA23.5x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Declarations0 total
No declarations found
0 of 0 declarations
About PHARMANUTRA PR PHARMANUTRA - PHN - THE BOARD OF DIRECTOR APPROVES THE 2022 SUSTAINABILITY REPORT
PHARMANUTRA is a company specialized in the health and pharmaceutical sector. The board of directors has approved the 2022 sustainability report.